Showing results (161-170 of 231) with videos related to

Sort By:
Pageof 24
Rheumatology (Oxford, England)|November 17, 2022
Systemic lupus erythematosus phenotypes formed from machine learning with a specific focus on cognitive impairmentMichelle Barraclough, Lauren Erdman, Juan Pablo Diaz-Martinez, et al.
Rheumatology (Oxford, England)|December 8, 2017
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics RegisterEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Arthritis Care & Research|April 19, 2022
Impact of Belimumab on Organ Damage in Systemic Lupus ErythematosusMurray B Urowitz, Cynthia Aranow, Yumi Asukai, et al.
Annals of the Rheumatic Diseases|April 30, 2015
PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locusJohn Bowes, Sabine Loehr, Ashley Budu-Aggrey, et al.
Cytokine|May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infectionVincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Ebiomedicine|November 13, 2022
Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunityJames I Robinson, Md Yuzaiful Md Yusof, Vinny Davies, et al.
Rheumatology (Oxford, England)|August 26, 2025
Coming to a hard stop? Effect of tapered tocilizumab after weekly tocilizumab cessation for giant cell arteritis: a multicentre evaluationVanessa Quick, Stephen Sah, Shirish Dubey, et al.
Rheumatology (Oxford, England)|November 12, 2023
Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in EnglandVanessa Quick, Mahdi Abusalameh, Sajeel Ahmed, et al.
Annals of the Rheumatic Diseases|August 19, 2024
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE studyCynthia Aranow, Cornelia F Allaart, Zahir Amoura, et al.
Lupus Science & Medicine|September 23, 2025
Towards a minimal core dataset for systemic lupus erythematosus studiesStephen McDonald, Jialin Teng, Chengde Yang, et al.
Pageof 24